Leflunomide, an immunorestoring drug for the therapy of autoimmune disorders, especially rheumatoid arthritis

Transplant Proc. 1996 Dec;28(6):3074-8.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
  • Antibody Formation / drug effects
  • Arthritis, Rheumatoid / drug therapy*
  • Autoimmune Diseases / drug therapy*
  • B-Lymphocytes / drug effects
  • B-Lymphocytes / immunology
  • Clinical Trials as Topic
  • Disease Models, Animal
  • Humans
  • Immune Tolerance
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use*
  • Isoxazoles / adverse effects
  • Isoxazoles / therapeutic use*
  • Leflunomide
  • Lymphocyte Activation / drug effects
  • Mammals

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Immunosuppressive Agents
  • Isoxazoles
  • Leflunomide